(Alliance News) - Itochu Corp and BHP Group Ltd on Thursday announced they have made the final investment decision for the development of the Ministers North iron ore deposit in Western Australia, moving the project into its construction phase. Read More
(Alliance News) - BHP Group Ltd on Thursday reported softer fourth quarter copper and iron ore output while annual results showed "record" iron ore volumes. Read More
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More
(Alliance News) - The Central Bank of Ireland is keeping its compliance with international law in handling prospectuses for Israel bonds "under review", its governor said, but added it was in "no doubt" that it complied with its obligations. Read More
BP PLC - London-based energy company - Agrees to sell most of BP Ventures' minority interests in more than 10 companies in its portfolio to Verdane OpCo AS. BP says the transaction supports its efforts to simplify its portfolio and maintain disciplined capital allocation. Verdane, the Oslo, Norway-based investment firm, will acquire the interests in the companies, while BP will retain investments in a "small number" of the companies "where the technology has the potential to create value for its businesses," says BP. Company notes the divestment is expected to be complete by the second quarter of 2027. Read More
(Alliance News) - DCC PLC on Wednesday said it extended its deadline for a takeover approach from a consortium led by Kohlberg Kravis Roberts & Co LP and including Energy Capital Partners LLC. Read More
(Alliance News) - Andy Burnham has declined to rule out introducing a wealth tax and suggested the government "might be having to ask for a little more" at some point to balance Britain's books. Read More
(Alliance News) - The FTSE 100 ended lower on Wednesday as weak miners kept London's lead index in check amid soft economic data in China. Read More
(Alliance News) - More than a third of Burberry Group PLC shareholders have voted against a new pay plan for directors which could see the chief executive officer earn up to GBP12.2 million. Read More
Costain Group PLC - Announces that United Utilities Group PLC extends its managed service provider contract by three years, taking the partnership to 10 years and covering the remainder of the AMP8 regulatory cycle. Costain has supported United Utilities since 2019, delivering more than 900 capital maintenance projects and around 9,000 responsive maintenance activities. The company says the extension supports United Utilities' GBP13.5 billion AMP8 investment programme and includes an option to continue the relationship through AMP9 to 2035. Read More
(Alliance News) - Blackrock World Mining Trust PLC on Wednesday announced a decline in net asset value per share during June, citing a fall in the prices of gold and aluminium. Read More
(Alliance News) - Ditch the state pension triple lock in the UK and consider scrapping some VAT exemptions to raise more for government spending, an influential economic think tank has suggested. Read More
(Alliance News) - British Steel could be nationalised within days after legislation to bring the firm into public ownership received a final seal of approval. Read More
GSK PLC - London-based pharmaceutical company - Completes takeover of Nuvalent Inc, a Boston, Massachusetts-based clinical-stage biopharmaceutical company focused on creating precisely targeted oncology therapies. The total value of the acquisition is about USD10.6 billion. Net of cash acquired, GSK's total investment is about USD9.4 billion. The transaction adds three lung cancer assets to GSK's oncology portfolio, with zidesamtinib and neladalkib "considered potential best-in-class assets", and under Food & Drug Administration review for ROS1-positive and ALK-altered non-small cell lung cancer. GSK says: "Both have received FDA breakthrough therapy and orphan drug designations. If approved, they are expected to launch in 2026 with multi-blockbuster potential." Read More